83 related articles for article (PubMed ID: 16124400)
21. Properties of multiphase microspheres of poly(D,L-lactic-co-glycolic acid) prepared by a potentiometric dispersion technique.
O'Donnell PB; Iwata M; McGinity JW
J Microencapsul; 1995; 12(2):155-63. PubMed ID: 7629658
[TBL] [Abstract][Full Text] [Related]
22. 188Re(V)-DMSA revisited: preparation and biodistribution of a potential radiotherapeutic agent with low kidney uptake.
Dadachova E; Chapman J
Nucl Med Commun; 1998 Feb; 19(2):173-81. PubMed ID: 9548202
[TBL] [Abstract][Full Text] [Related]
23. Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems.
Lu W; Park TG
PDA J Pharm Sci Technol; 1995; 49(1):13-9. PubMed ID: 7757453
[TBL] [Abstract][Full Text] [Related]
24. Clonazepam microencapsulation in poly-D,L-lactide-co-glycolide microspheres.
Benelli P; Conti B; Genta I; Costantini M; Montanari L
J Microencapsul; 1998; 15(4):431-43. PubMed ID: 9651865
[TBL] [Abstract][Full Text] [Related]
25. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
[TBL] [Abstract][Full Text] [Related]
26. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
Díez S; Tros de Ilarduya C
Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
[TBL] [Abstract][Full Text] [Related]
27. Microspheres prepared with different co-polymers of poly(lactic-glycolic acid) (PLGA) or with chitosan cause distinct effects on macrophages.
Bitencourt Cda S; Silva LB; Pereira PA; Gelfuso GM; Faccioli LH
Colloids Surf B Biointerfaces; 2015 Dec; 136():678-86. PubMed ID: 26497115
[TBL] [Abstract][Full Text] [Related]
28. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
[TBL] [Abstract][Full Text] [Related]
29. How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment.
Siepmann J; Elkharraz K; Siepmann F; Klose D
Biomacromolecules; 2005; 6(4):2312-9. PubMed ID: 16004477
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.
He Y; Liu Y; Liu Y; Wang J; Zhang X; Lu W; Ma Z; Zhu X; Zhang Q
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3983-8. PubMed ID: 16936114
[TBL] [Abstract][Full Text] [Related]
31. Fabrication of double-walled microspheres for the sustained release of doxorubicin.
Tan EC; Lin R; Wang CH
J Colloid Interface Sci; 2005 Nov; 291(1):135-43. PubMed ID: 15964579
[TBL] [Abstract][Full Text] [Related]
32. Stabilization and immune response of HBsAg encapsulated within poly(lactic-co-glycolic acid) microspheres using HSA as a stabilizer.
Xu W; He J; Wu G; Xiong F; Du H; Wang G
Int J Pharm; 2015 Dec; 496(2):332-41. PubMed ID: 26453785
[TBL] [Abstract][Full Text] [Related]
33. 99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.
Blower PJ; Kettle AG; O'Doherty MJ; Coakley AJ; Knapp FF
Eur J Nucl Med; 2000 Sep; 27(9):1405-9. PubMed ID: 11007525
[TBL] [Abstract][Full Text] [Related]
34. [The study on the in-vitro stability of Tc(V)-99m dimercaptosuccinic acid].
Lee BF; Chung KL; Jong SB; Yang CC; Chen CL; Chen YJ; Chen SL; Yu HS; Ting G; Shen LH
Kaohsiung J Med Sci; 1996 Sep; 12(9):495-502. PubMed ID: 8819352
[TBL] [Abstract][Full Text] [Related]
35. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
Duvvuri S; Janoria KG; Mitra AK
J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
[TBL] [Abstract][Full Text] [Related]
36. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release.
Kim HK; Park TG
J Control Release; 2004 Jul; 98(1):115-25. PubMed ID: 15245894
[TBL] [Abstract][Full Text] [Related]
37. Pluronic F127 gel effectively controls the burst release of drug from PLGA microspheres.
Wang Y; Gao JQ; Chen HL; Zheng CH; Liang WQ
Pharmazie; 2006 Apr; 61(4):367-8. PubMed ID: 16649559
[TBL] [Abstract][Full Text] [Related]
38. Effect of the molecular weight of poly(ethylene glycol) used as emulsifier on alpha-chymotrypsin stability upon encapsulation in PLGA microspheres.
Castellanos IJ; Flores G; Griebenow K
J Pharm Pharmacol; 2005 Oct; 57(10):1261-69. PubMed ID: 16259754
[TBL] [Abstract][Full Text] [Related]
39. In vitro degradation and controlled release behavior of D,L-PLGA50 and PCL-b-D,L-PLGA50 copolymer microspheres.
Dong CM; Guo YZ; Qiu KY; Gu ZW; Feng XD
J Control Release; 2005 Sep; 107(1):53-64. PubMed ID: 16005093
[TBL] [Abstract][Full Text] [Related]
40. Influence of additives on the release profile of nifedipine from poly(DL-lactide-co-glycolide) microspheres.
Sansdrap P; Moës AJ
J Microencapsul; 1998; 15(5):545-53. PubMed ID: 9743911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
